back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-10-20 12:02 Tx date 2025-10-09 |
$INM
InMed Pharmaceuticals Inc. |
Klompas, Neil
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
3,500 | ||
| Filed 2025-05-20 16:52 Tx date 2025-05-16 |
$NGEN
NervGen Pharma Corp. |
Klompas, Neil
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$240,000
+60,000 vol $4.00 each |
210,000 | |
| Filed 2024-07-22 13:17 Tx date 2024-07-19 |
$NGEN
NervGen Pharma Corp. |
Klompas, Neil
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$427,500
+150,000 vol $2.85 each |
150,000 | |
| Filed 2024-07-22 13:16 Tx date 2024-07-19 |
$NGEN
NervGen Pharma Corp. |
Klompas, Neil
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-17 10:35 Tx date 2023-03-17 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Klompas, Neil
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-43,961 vol |
4,885 | |
| Filed 2022-07-05 17:51 Tx date 2022-07-05 |
$ZYME
Zymeworks Inc. |
Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,877
+1,525 vol $4.51 each |
14,801 | |
| Filed 2022-06-10 14:44 Tx date 2022-06-07 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Klompas, Neil
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,020
+13,000 vol $0.54 each |
48,846 | |
| Filed 2022-03-11 18:11 Tx date 2022-03-10 |
$ZYME
Zymeworks Inc. |
Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,495.52
-2,979 vol $6.88 each |
13,276 | |
| Filed 2022-03-11 18:07 Tx date 2022-03-10 |
$ZYME
Zymeworks Inc. |
Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,708 vol |
16,255 | |
| Filed 2022-03-11 18:06 Tx date 2022-03-10 |
$ZYME
Zymeworks Inc. |
Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,500 vol |
13,547 | |
| Filed 2022-03-11 18:05 Tx date 2022-03-10 |
$ZYME
Zymeworks Inc. |
Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-2,708 vol |
7,917 | |
| Filed 2022-03-11 18:03 Tx date 2022-03-10 |
$ZYME
Zymeworks Inc. |
Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-2,500 vol |
10,625 | |
| Filed 2022-03-11 17:56 Tx date 2022-03-10 |
$ZYME
Zymeworks Inc. |
Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
768,809 | |
| Filed 2022-01-07 21:23 Tx date 2022-01-07 |
$ZYME
Zymeworks Inc. |
Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,861
+277 vol $13.94 each |
11,047 | |
| Filed 2021-07-13 14:26 Tx date 2021-07-05 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Klompas, Neil
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$39,300
+10,000 vol $3.93 each |
35,846 | |
| Filed 2021-07-08 17:02 Tx date 2021-07-06 |
$ZYME
Zymeworks Inc. |
Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,817
+299 vol $29.49 each |
10,770 | |
| Filed 2021-03-12 18:12 Tx date 2021-03-10 |
$ZYME
Zymeworks Inc. |
Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-49,808.7375
-1,425 vol $34.95 each |
10,471 | |
| Filed 2021-03-12 18:09 Tx date 2021-03-10 |
$ZYME
Zymeworks Inc. |
Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,500 vol |
11,896 | |
| Filed 2021-03-12 18:07 Tx date 2021-03-10 |
$ZYME
Zymeworks Inc. |
Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-2,500 vol |
13,125 | |
| Filed 2021-03-12 18:06 Tx date 2021-03-10 |
$ZYME
Zymeworks Inc. |
Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+8,125 vol |
15,625 |